WebFounded Date 2024. Operating Status Active. Last Funding Type Undisclosed. Company Type For Profit. Jelikalite creates medical equipment for kids with autism spectrum … Web23 apr 2024 · JelikaLite uses PRM therapy to reduce autism symptoms BRSF sees this as an important step forward in wider adoption of affordable, accessible EEG systems The neurology-focused medical device and software company Brain Scientific (OTCQB: BRSF) announced on March 16, 2024, it is collaborating with JelikaLite in a clinical trial.
JelikaLite obtains FDA breakthrough device designation for …
Web16 mar 2024 · JelikaLite is a biotech company developing individualized solutions to children with autism and other neurological conditions. JelikaLite believes that children … Web6 gen 2024 · JelikaLite Corp. believes that it can provide relief to patients and families by reducing children's autism symptoms. Children will be able to better integrate into the … bufferline close tab
FDA Grants Breakthrough Device Designation to JelikaLite
Web6 gen 2024 · NEW YORK-- ( BUSINESS WIRE )-- JelikaLite Corp, a medical technology company, announced today that the U.S. Food and Drug Administration (FDA) has granted the Breakthrough Device Designation to its Cognilum System for the reduction of symptoms of moderate to severe autism spectrum disorder in pediatric patients who are 2 to 6 … WebJelikaLite Dec 2024 - Present 2 years 5 months. New York, New York, United States VP Advanced Research DJO Global Dec 2024 - Apr 2024 … Web16 mar 2024 · JelikaLite’s Cognilum™ device is being developed to deliver treatment through transcranial photobiomodulation; the science uses infrared light, delivered through LEDs, ... crocker house country inn hancock maine